Hip bone graft may boost shoulder fracture recovery
NCT ID NCT07538700
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether adding a piece of donated hip bone (femoral allograft) to standard plate surgery helps people aged 40-70 recover better from severe shoulder fractures. Half the participants will get the graft plus a plate, the other half just the plate. Researchers will compare shoulder function, pain, and quality of life over two years.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- femoral allograft (hip bone graft) used alongside locking plate fixation
- What this could lead to
- If it works, this could provide a better surgical option for severe shoulder fractures, leading to improved function and quality of life.
- What could go wrong
- This is a small, early-stage trial with only 56 participants, so results may not apply to everyone. Adding a bone graft also carries risks like infection or graft failure.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 56 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
May 2025
- Expected to finish
-
May 2029
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
40 to 70 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients between 40 and 70 years * Presenting with acute (\< 3 weeks) 3- or 4-part PHF (NEER classification) Be able to understand and communicate in Dutch; Patient must be competent to make decisions; Patient is willing and able to complete scheduled study procedures Provide written IC. Exclusion Criteria: * Head-split fractures; * Pathological fractures due to malignancy or metastases; * Individuals diagnosed with dementia or residing in institutional care or other cognitive impairment; * Terminal illness; Patients with convulsive disorders, collagen diseases, and any other condition that might affect the mobility of the shoulder joint; Active joint or systemic infection; History of prior surgery on the same shoulder; Previous fracture in the same shoulder; Psychiatric illness that precludes informed consent.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Proximal humeral fractures are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Tergooi Medical Center
RECRUITINGHilversum, Netherlands